Abuse liability studies of opioid agonist-antagonists in humans
Open Access
- 1 June 1991
- journal article
- review article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 28 (1) , 49-82
- https://doi.org/10.1016/0376-8716(91)90053-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Discrimination of butorphanol and nalbuphine in opioid-dependent humansPharmacology Biochemistry and Behavior, 1990
- Patient-controlled AnalgesiaAnesthesiology, 1988
- Buprenorphine detoxification from opiod dependence: A pilot studyLife Sciences, 1988
- Effects of buprenorphine in heroin addictsDrug and Alcohol Dependence, 1987
- Evaluation of tilidine for morphine-like subjective effects and euphoriaDrug and Alcohol Dependence, 1986
- Choice of blind methadone dose increases by methadone maintenance patientsDrug and Alcohol Dependence, 1986
- The Clinical Pharmacology of Pentazocine and TripelennamineAdvances in Alcohol & Substance Abuse, 1986
- Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effectsDrug and Alcohol Dependence, 1986
- Clinical experience with T's and B'sDrug and Alcohol Dependence, 1985
- Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tabletsDrug and Alcohol Dependence, 1984